Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells
Главные авторы: | Dan Nakano, Takumi Kawaguchi, Tsubasa Tsutsumi, Masako Hayakawa, Sachiyo Yoshio, Hironori Koga, Takuji Torimura |
---|---|
Формат: | Статья |
Язык: | English |
Опубликовано: |
Wiley
2022-04-01
|
Серии: | JGH Open |
Предметы: | |
Online-ссылка: | https://doi.org/10.1002/jgh3.12730 |
Схожие документы
-
Gene cloning and expression analysis of Gro/KC by primary hepatocytes
по: GH. Hassanshahi, и др.
Опубликовано: (2007-01-01) -
Drug Transporter Expression and Activity in Human Hepatoma HuH-7 Cells
по: Elodie Jouan, и др.
Опубликовано: (2016-12-01) -
Metabolic dysfunction-associated fatty liver disease is a ubiquitous latent cofactor in viral- and alcoholic-related hepatocellular carcinoma: Editorial on “Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis”
по: Toru Nakamura, и др.
Опубликовано: (2024-10-01) -
Chemokines, chemokine receptors and disease : current topics in membranes /
по: Schwiebert, Lisa M.
Опубликовано: (2005) -
A rapid increase in lysophospholipids after geranylgeranoic acid treatment in human hepatoma-derived HuH-7 cells revealed by metabolomics analysis
по: Yoshihiro Shidoji, и др.
Опубликовано: (2021-12-01)